S.P. Medicines Private Limited
About S.P. Medicines Private Limited
Data last updated:
S.P. Medicines Private Limited is a private limited company based in Midnapore, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 December 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2002PTC095515. Its GSTIN is 19AAICS4981K1ZM (West Bengal).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Sukumar Panda (Managing Director) and Paramita Panda (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Kashudiram Nagar, Midnapore, West Bengal, India – 721101.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.57 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹4.59 Lakh (net margin 0.4%) and EBITDA of ₹15.01 Lakh (EBITDA margin 1.4%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 14% over five years.
As per MCA filings, the company has open charges of ₹80 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
S.P. Medicines Private Limited's registered office is in Midnapore, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKashudiram Nagar, Midnapore, West Bengal, India – 721101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of S.P. Medicines Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of S.P. Medicines is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of S.P. Medicines Private Limited, buy the company report.
Financials of S.P. Medicines Private Limited
FY 2024 filings availableS.P. Medicines Private Limited reported revenue of ₹10.57 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 14%. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.59 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of S.P. Medicines Private Limited, buy the company report.
Board of directors of S.P. Medicines Private Limited
S.P. Medicines has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suvayu Panda | Director | 16 Dec 2002 | 23 Years 10 Months | Current |
| Paramita Panda | Whole-Time Director | 26 Oct 2017 | 8 Years 11 Months | Current |
| Palima Panda | Director | 16 Dec 2002 | 23 Years 10 Months | Current |
| Sukumar Panda | Managing Director | 16 Dec 2002 | 23 Years 10 Months | Current |
Peer comparison
S.P. Medicines Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rajesh Pharma Private Limited | ₹10.62 Cr (FY 2025) | -1.0% | Alwar, Rajasthan, India | |||
| Aashirwad Pharma International Private Limited | ₹10.59 Cr (FY 2024) | 5222.0% | Pune, Maharashtra, India | |||
| S.P. Medicines Private Limitedthis company | ₹10.57 Cr (FY 2025) | ₹4.59 Lakh | 0.4% | 3.0% | Midnapore, West Bengal, India | |
| Shani Raj Enterprises Private Limited | ₹10.56 Cr (FY 2025) | -35.0% | Delhi, India | |||
| Parsan Overseas Private Limited | ₹10.56 Cr (FY 2025) | -9.0% | New Delhi, Delhi, India |
To see the full peer comparison of S.P. Medicines Private Limited, buy the company report.
Auditor
S.P. Medicines Private Limited is audited by T K Mandal & Co for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T K Mandal & Co | FY 2022 | 320037E |
Shareholding
The shareholding of S.P. Medicines Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of S.P. Medicines Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Sep 2006 | 10021948 | Bank of India | ₹80 Lakh | Open |
To see the full charge records of S.P. Medicines Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving S.P. Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for S.P. Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
S.P. Medicines has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAICS4981K1ZM | West Bengal | Active | 06 Jul 2017 |
To see the full GST registrations and return filing status of S.P. Medicines Private Limited, buy the company report.
Recent activity
S.P. Medicines Private Limited has 5 board changes on record since 2002: 4 appointments and 1 cessation. The latest: Paramita Panda was appointed as Whole-Time Director on 26 Oct 2017.
Frequently asked questions
S.P. Medicines is an active private limited company based in Midnapore, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 December 2002 (24+ years old) and is registered under CIN U24239WB2002PTC095515.
S.P. Medicines has 4 current directors:
- Sukumar Panda - Managing Director
- Paramita Panda - Whole-Time Director
- Suvayu Panda - Director
- Palima Panda - Director
The latest financial statements of S.P. Medicines on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of S.P. Medicines is 19AAICS4981K1ZM, registered in West Bengal.
The CIN (Corporate Identification Number) of S.P. Medicines is U24239WB2002PTC095515. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
S.P. Medicines was incorporated on 16 December 2002, making it 24+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of S.P. Medicines by revenue are Rajesh Pharma Private Limited, Aashirwad Pharma International Private Limited, Shani Raj Enterprises Private Limited, Parsan Overseas Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Paramita Panda was appointed as Whole-Time Director on 26 Oct 2017. Souvik Panda ceased to be Director on 26 Mar 2016. Palima Panda was appointed as Director on 16 Dec 2002. S.P. Medicines has 5 board changes on record in total.
The registered office of S.P. Medicines is at Kashudiram Nagar, Midnapore, West Bengal, India – 721101.
S.P. Medicines operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
S.P. Medicines has open charges of ₹80 Lakh and no satisfied charges on record as per latest MCA filings.